HKSE - Delayed Quote HKD

GAUSH MEDITECH (2407.HK)

Compare
10.620 -0.700 (-6.18%)
At close: October 25 at 4:08 PM GMT+8
Loading Chart for 2407.HK
DELL
  • Previous Close 11.320
  • Open 11.420
  • Bid 10.620 x --
  • Ask 10.640 x --
  • Day's Range 10.480 - 12.420
  • 52 Week Range 8.450 - 42.050
  • Volume 6,502,000
  • Avg. Volume 976,884
  • Market Cap (intraday) 1.571B
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) 16.09
  • EPS (TTM) 0.660
  • Earnings Date --
  • Forward Dividend & Yield 1.10 (10.36%)
  • Ex-Dividend Date Jun 24, 2024
  • 1y Target Est 15.60

Gaush Meditech Ltd. engages in the research and development, production, and distribution of ophthalmic medical equipment and consumables, and the provision of technical services to end customers. The company's product portfolio comprises of proprietary products, which it develops and manufactures, as well as distribution products of its brand partners, which it distributes, covering seven ophthalmology sub-specialties where ophthalmic medical devices are utilized for diagnosis, treatment, or surgeries, being vitreoretinal diseases, cataracts, refractive surgery, glaucoma, ocular surface diseases, optometry, and pediatric ophthalmology. Gaush Meditech Ltd. was founded in 1998 and is headquartered in Beijing, the People's Republic of China.

www.gaush.com

872

Full Time Employees

December 31

Fiscal Year Ends

Recent News: 2407.HK

View More

Performance Overview: 2407.HK

Trailing total returns as of 10/25/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

2407.HK
69.47%
HANG SENG INDEX
20.78%

1-Year Return

2407.HK
70.75%
HANG SENG INDEX
21.18%

3-Year Return

2407.HK
79.26%
HANG SENG INDEX
5.79%

5-Year Return

2407.HK
79.26%
HANG SENG INDEX
5.79%

Compare To: 2407.HK

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: 2407.HK

View More

Valuation Measures

Annual
As of 10/25/2024
  • Market Cap

    1.57B

  • Enterprise Value

    1.43B

  • Trailing P/E

    15.97

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.07

  • Price/Book (mrq)

    0.94

  • Enterprise Value/Revenue

    0.97

  • Enterprise Value/EBITDA

    4.52

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    6.73%

  • Return on Assets (ttm)

    3.79%

  • Return on Equity (ttm)

    5.60%

  • Revenue (ttm)

    1.35B

  • Net Income Avi to Common (ttm)

    90.7M

  • Diluted EPS (ttm)

    0.660

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    754.2M

  • Total Debt/Equity (mrq)

    40.21%

  • Levered Free Cash Flow (ttm)

    195.18M

Research Analysis: 2407.HK

View More

Company Insights: 2407.HK

Research Reports: 2407.HK

View More

People Also Watch